Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study.

Natalie J AtallahVahe S Panossian Christine J AtallahAndrej SchwabeSascha JohannesJan WiemerMichael K Mansour

Published in: Open forum infectious diseases (2022)

MR-proADM functions as a valuable biomarker for the early risk stratification and detection of severe disease progression of patients with COVID-19. In the prediction of death, MR-proADM performed better compared to many other commonly used biomarkers.

Keyphrases

coronavirus disease
contrast enhanced
magnetic resonance
loop mediated isothermal amplification
magnetic resonance imaging
computed tomography